Follow Us:
< back

Share

3D bioprinted models shed light on neurodegenerative diseases

Image for 3D bioprinted models shed light on neurodegenerative diseases

The onset of many neurodegenerative diseases, such as Alzheimer’s and stroke, is directly related to the dysfunction of the neurovascular unit (NVU). For this reason, 3D models that closely mimic the complexity of the NVU are needed to investigate what goes wrong during pathogenesis. Tissue engineering offers a plethora of advanced techniques to achieve this goal. Among them, bioprinting seems the most promising, allowing the deposition of novel biomaterials and bioinks to recreate NVU-mimicking structures.

A recent review by researchers from The University of Manchester has highlighted the advantages and promising outcomes of using bioprinting in the study of neurodegenerative diseases.

 

Neurovascular unit components

 

The NVU is a brain-localized unit, composed of a vascular and a neural component. The correct cross-talk between these two components is fundamental for brain health, since it regulates transport of oxygen and nutrients to the brain, along with removal of toxic compounds, preventing neuroinflammation and neurodegeneration.

 

The NVU extracellular matrix (ECM) represents the medium through which neural and vascular components can interact, providing physical support and biochemical cues to embedded cells. Indeed, the ECM can provide stimuli to promote growth of new neurons and blood vessels, as well as maintenance of brain health over time. For these reasons, disruption of the NVU has been linked to the onset and progression of severe neurodegenerative diseases, such as Alzheimer’s, vascular dementia, Parkinson’s and stroke.

Read full story

More News:

FOR DOCTORS AND medical researchers repairing the human body, a 3D printer has become almost as valuable as an x-ray machine, microscope, or a sharp scalpel. Bioengineers are using 3D printers to make more durable hip and knee joints, prosthetic limbs and, recently, to produce living tissue attached to a scaffold of printed material. Researchers...

Read more

Via Davide Sher, 3D Printing Media Network We spoke with CEO Erik Gatenholm about the company’s recent acquisitions and future goals. CELLINK‘s rise from a bioink startup to a bioprinting market global leader has been lightning fast. In 2015 I did my first interview, with founders Erik Gatenholm (CEO), Hector Martinez Avila (CTO) and Gusten...

Read more

PRESS RELEASE Gothenburg, Sweden December 5th, 2018, 08:30 CET CELLINK and Prellis Biologics Inc. sign partnership to commercialize high-resolution holographic bioprinting technology for micro-printing. The partners will utilize their IP, expertise, and know-how to offer the first system enabling ultra-high resolution bioprinting of microstructures such as vascular networks or capillaries. The technology is an important...

Read more